Pioneering generative biology to create breakthrough therapeutics.
Location: United States, Massachusetts, Cambridge
Employees: 51-200
Investors 2
Date | Name | Website |
26.03.2022 | ARCH Ventu... | archventur... |
- | Altitude L... | altitudels... |
Mentions in press and media 13
Date | Title | Description | Source |
16.09.2023 | USA-based Generate:Biomedicines closes Series C financing at... | Somerville, USA-based clinical-stage biotherapeutics company pioneering a machine-learning-powered g... | vcbay.news... |
15.09.2023 | Generate:Biomedicines Closes $273M Series C Financing | Generate:Biomedics, a Somerville, MA-based clinical-stage biotherapeutics company, raised $273M in S... | finsmes.co... |
28.04.2023 | Biomedicines and MD Anderson Enter Co-Development and Commer... | Generate:Biomedicines and The University of Texas MD Anderson Cancer Center announced a strategic co... | aithority.... |
05.12.2022 | Вдохновлено DALL-E: как биолаборатории используют ИИ для изо... | Недавно сразу две лаборатории независимо друг от друга представили программы на базе диффузионных мо... | rb.ru/stor... |
11.08.2022 | Prellis Biologics hires new CEO, raises $35M towards 3D biop... | Prellis Biologics has raised $35 million and appointed a new CEO as it seeks to advance the developm... | 3dprinting... |
01.12.2021 | Digital health news, funding roundup in the prior week; Nove... | Amazon Health sells healthcare services to Hilton; Athenahealth acquired for $17 Billion Where tech... | vator.tv/n... |
24.11.2021 | Generate Biomedicines Raises $370M in Series B Funding Round | Generate Biomedicines, a Cambridge, MA-based provider of a drug generation platform, raised $370M in... | finsmes.co... |
19.11.2021 | Generate Biomedicines hauls in $370M Series B | Generate Biomedicines has raised $370 million from investors including Flagship Pioneering, Altitude... | pitchbook.... |
18.11.2021 | Generate Biomedicines Announces First External Equity Raise ... | Generate Biomedicines, whose machine learning-powered Generative Biology platform can rapidly invent... | marketscre... |
18.11.2021 | Generate Biomedicines raises $370M Series B with a focus on ... | The drug development space is continuing to attract more and more investment. On Thursday, another m... | techcrunch... |
Show more